David Leggat

5PUBLICATIONS
72CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 12, 2024
Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming.

Allan C deCamp, Martin M Corcoran, William J Fulp

|Jan 03, 2024
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.

Madhu Prabhakaran, Flavio Matassoli, David Leggat

|May 24, 2023
A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.

Kristen W Cohen, Stephen C De Rosa, William J Fulp

|Dec 01, 2022
Vaccination induces HIV broadly neutralizing antibody precursors in humans.

David J Leggat, Kristen W Cohen, Jordan R Willis

|Jan 26, 2021
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center.

Leila Eslamizar, Constantinos Petrovas, David J Leggat

Pageof 1